红花液联合低分子肝素治疗不稳定型心绞痛疗效分析

目的:探讨红花液联合低分子肝素治疗不稳定型心绞痛临床疗效。方法:收治不稳定型心绞痛患者124例,对照组给与肠溶阿司匹林、阿托伐他汀进行治疗,观察组在对照组的基础上加用红花液20ml加入25ml5%葡萄糖中,静滴,低分子肝素6000U腹壁皮下注射,2次/日,连续注射7天,两组均治疗2周观察疗效。结果:观察组胸闷痛总有效率为95.2%,伴随症状总有效率为98.4%,心电图恢复正常总有效率为80.6%。对照组胸闷痛总有效率为75.8%,伴随症状总有效率为67.7%,心电图恢复正常总有效率为64.5%。观察组总有效率为98.4%,对照组总有效率为71.0%,两组疗效比较差异有显著性(P<0.05)。结论:联合低分子肝素治疗不稳定型心绞痛疗效显著,安全可靠。

Objective：To investigate the clinical efficacy of the saffron liquid combined low molecular weight heparin treatment of unstable angina. Collected in our hospital in February 2011 - 124 cases of pa- tients with unstable angina hospitalized in March 2012, the control group given aspi- rin, atorvastatin treatment in the observation group in the control group based on the use of saffron liquid 20ml in add 25ml 5% glucose intravenous infusion, low molecular weight heparin 6000U abdominal subcutaneous,2 times/d, continuous infusion of 7d, two groups of patients were treated for 2 weeks of observation. Results：The observation group chest pain is the total effective rate was 95.2%, accompanied by symptoms of total effective rate was 98.4%, electrocardiogram returned to normal the total effective rate of 80. 6%. Chest pain of the control group, the total effective rate was 75.8%, accompanied by symptoms of the total effective rate was 67.7%, electrocardiogram returned to normal the total effective rate 64. 5%; The total effective rate was 98.4%, control group, the total effective rate was 71.0% in both groups The efficacy of a significant difference （ P 〈 0. 05 ）. Conclusion：Joint low molecular weight heparin in the treatment of unstable angina pectoris, safe and reliable.